Testing ZG005 plus donafenib for advanced solid tumors
Part of Cancer clinical trials.
This trial tests two drugs, ZG005 and donafenib, together in people with advanced solid tumors that have not responded to other treatments. The goal is to see if this combination is safe and helps shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You should be able to carry out daily activities with little help (ECOG score 0 or 1).
- Your doctor expects you to live at least 3 months.
- You must agree to join the study after understanding it fully.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
This trial is testing a new combination of two drugs (ZGGS18 and ZG005) for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the combination is safe and effective.
This trial tests a new drug called ZG005 in people with advanced solid tumors that have not spread to the brain. It aims to see if the drug is safe and can help shrink tumors.
This trial tests a new drug combination (ZG005, Gecacitinib, and chemotherapy) for people with advanced solid tumors that cannot be removed by surgery. It aims to see if this combination can shrink tumors or slow their growth.
This Phase 1 trial studies ZG0895.HCl, a new experimental treatment, in people with advanced solid cancers. It’s mainly to check safety and how the body responds, and it may help by shrinking or controlling tumors if the drug works.
This Phase 1/2 trial studies ZGGS18, a new medicine, in people with advanced solid tumors that either no longer respond to standard treatment or for whom standard treatment isn’t an option. The goal is to see how the drug works and what side effects it causes.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.